# University of Siena

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/university-of-siena/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 93.1 |
| Citations | 4,868,143 |
| City | Siena |
| Country | IT |
| Description | University of Siena is a research organisation in Siena, IT. OpenAlex records 61,317 works and 4,868,143 citations for it. 9,237 researchers list it as their most recent affiliation. |
| Homepage | https://www.unisi.it |
| OpenAlex ID | https://openalex.org/I102064193 |
| Researchers | 9,237 |
| ROR ID | https://ror.org/01tevnk56 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q1245999 |
| Works | 61,317 |

## University collaborators

- [Institut Gustave Roussy](https://scholariq.org/institutions/institut-gustave-roussy/)
- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)
- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

## University papers

Showing 12 of 76.

- [Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK](https://scholariq.org/papers/safety-and-efficacy-of-the-chadox1-ncov-19-vaccine-azd1222-against-sars-cov-2-an/)
- [Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma](https://scholariq.org/papers/ipilimumab-plus-dacarbazine-for-previously-untreated-metastatic-melanoma/)
- [Cerebral Blood Flow in Dementia](https://scholariq.org/papers/cerebral-blood-flow-in-dementia/)
- [Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/nivolumab-versus-chemotherapy-in-patients-with-advanced-melanoma-who-progressed/)
- [Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)](https://scholariq.org/papers/evidence-based-guidelines-on-the-therapeutic-use-of-repetitive-transcranial/)
- [Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma](https://scholariq.org/papers/adjuvant-pembrolizumab-versus-placebo-in-resected-stage-iii-melanoma/)
- [Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS)](https://scholariq.org/papers/evidence-based-guidelines-on-the-therapeutic-use-of-transcranial-direct-current/)
- [Genetic mechanisms of critical illness in COVID-19](https://scholariq.org/papers/genetic-mechanisms-of-critical-illness-in-covid-19-2/)
- [Rett syndrome: Revised diagnostic criteria and nomenclature](https://scholariq.org/papers/rett-syndrome-revised-diagnostic-criteria-and-nomenclature/)
- [Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials](https://scholariq.org/papers/single-dose-administration-and-the-influence-of-the-timing-of-the-booster-dose/)
- [Mapping the human genetic architecture of COVID-19](https://scholariq.org/papers/mapping-the-human-genetic-architecture-of-covid-19/)
- [Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019](https://scholariq.org/papers/management-of-epithelial-precancerous-conditions-and-lesions-in-the-stomach-maps/)

## University researchers

- [Giacomo De Riu](https://scholariq.org/researchers/giacomo-de-riu/)
- [Federico Franchi](https://scholariq.org/researchers/federico-franchi/)
- [Giancarlo Palasciano](https://scholariq.org/researchers/giancarlo-palasciano/)

## University top topics

Showing 8 of 24.

- [Particle physics theoretical and experimental studies](https://scholariq.org/topics/particle-physics-theoretical-and-experimental-studies/)
- [Advanced Antenna and Metasurface Technologies](https://scholariq.org/topics/advanced-antenna-and-metasurface-technologies/)
- [Astrophysics and Cosmic Phenomena](https://scholariq.org/topics/astrophysics-and-cosmic-phenomena/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [High-Energy Particle Collisions Research](https://scholariq.org/topics/high-energy-particle-collisions-research/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [Dental materials and restorations](https://scholariq.org/topics/dental-materials-and-restorations/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.